Document is current
Any future updates will be listed below
-
Authors
Wu, Qianxin
Ferry, Quentin R. V.
Baeumler, Toni A.
Michaels, Yale S.
Vitsios, Dimitrios M. http://orcid.org/0000-0002-8939-5445
Habib, Omer
Arnold, Roland
Jiang, Xiaowei http://orcid.org/0000-0002-6030-1249
Maio, Stefano
Steinkraus, Bruno R.
Tapia, Marta
Piazza, Paolo
Xu, Ni
Holländer, Georg A.
Milne, Thomas A. http://orcid.org/0000-0002-0413-4271
Kim, Jin-Soo
Enright, Anton J. http://orcid.org/0000-0002-6090-3100
Bassett, Andrew R. http://orcid.org/0000-0003-1632-9137
Fulga, Tudor A.
- License Information
-
More Information
Article History
Received: 2 May 2017
Accepted: 19 July 2017
First Online: 13 December 2017
Competing interests
: T.A.M. is one of the founding shareholders of Oxstem Oncology (OSO), a subsidiary company of OxStem Ltd. J.-S.K. is a co-founder and shareholder of ToolGen, Inc., a biotechnology company focused on genome editing. The remaining authors declare no competing financial interests.
